Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine Post published:August 18, 2021 Post category:Press Release
Psyched Wellness Submits Applications for Four Further Provisional Patents Surrounding Its Work on the AME-1 Post published:August 17, 2021 Post category:Press Release
Diamond Therapeutics Announces Health Canada Approval of Clinical Trial with Low-Dose Psilocybin Post published:August 17, 2021 Post category:Press Release
Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion Post published:August 17, 2021 Post category:Press Release
MindMed Joins Critical Path Institute’s Patient-Reported Outcome Consortium Post published:August 17, 2021 Post category:Press Release
Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer Post published:August 17, 2021 Post category:Press Release
Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update Post published:August 17, 2021 Post category:Press Release
Filament Health Announces Q2 2021 Financial Results Post published:August 16, 2021 Post category:Press Release
PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs Post published:August 16, 2021 Post category:Press Release
Mindset Pharma Announces Publication of Three PCT Patent Applications for Its Next Generation Psychedelic Drug Candidates Post published:August 16, 2021 Post category:Press Release